Pharma
We fact-checked the hype behind the Eledon Pharmaceuticals Type 1 diabetes treatment
In the words of Leslie Knope: “Diabetes. Let’s dia-beat-this!”
Clinical Trials & Evidence Generation
Comprehensive coverage of clinical trials & evidence generation news, trends, and expert analysis, providing the critical context healthcare professionals need.
Pharma
Immuneering CEO shares his cancer drug development strategy
“Slow and steady” beats “flashy” when it comes to treating cancer, CEO Ben Zeskind says.
Pharma
Biotechs could save time, money from clinical trial rule change
Testing the safety and efficacy of medications will still depend on the company and the disease.
Pharma
Support for psychedelic treatments means full steam ahead at Compass, despite stock drop
Investors were seemingly not satisfied with psilocybin trial results, but the psychedelic health community disagrees.
Pharma
Pig kidney pioneers talk next steps, first-ever clinical trials at Orlando conference
Oink if you love science!
Pharma
How digital twins could change clinical trials
Digital twins can cut time and costs associated with running drug studies.
Pharma
RIP simufilam, we hardly knew ye
On November 25, Cassava Sciences ended a Phase 3 trial of its controversial Alzheimer’s drug, simufilam, following years of scrutiny.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
